Signify Bio
PrivateLast Round
Seed
Jun 5, 2025
Total Funding Raised
$15M
Momentum Score
50 /100
Company Overview
Signify Bio is a biotechnology company transforming the development of in situ protein therapeutics by leveraging the human body’s natural ability to produce proteins.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Signify Bio Comps
Public and private peers based on sector, stage, and business model.
Signify Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 5, 2025 |
Signify Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BrightEdge | Seed |
| Danaher Ventures | Seed |
| Actium Group | Seed |
| Bill & Melinda Gates Foundation Strategic Investment Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 5, 2025
$15M raised in Seed round.
- Jun 5, 2025
Biotech company officially launched operations in Dallas.
Signify Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Signify Bio's valuation, stock price, and market status.